Novavax Inc (NASDAQ:NVAX)

During the Trading Day
7.82 +0.22 / +2.89%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.85 +0.03 / +0.38%
Volume: 64.4K
Health Technology

Company Description

Novavax, Inc. is a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles and recombinant nanoparticle vaccines. Its product pipeline targets a variety of infectious diseases and currently has completed clinical trials that target pandemic influenza (H5N1), seasonal influenza and Respiratory Syncytial Virus. Novavax was founded in 1987 and is headquartered in Gaithersburg, MD.

Contact Information

Novavax, Inc.
20 Firstfield Road
Gaithersburg Maryland 20878
P:(240) 268-2000
Investor Relations:



Mutual fund holders39.57%
Other institutional23.53%
Individual stakeholders10.27%

Top Executives

Stanley C. ErckPresident, Chief Executive Officer & Director
Barclay A. PhillipsChief Financial Officer, Treasurer & Senior VP
Gregory M. GlennSenior Vice President-Research & Development
Louis F. FriesChief Medical Officer & Vice President
Jill HoytVice President-Human Resources & Administration

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.